US 7,803,806 B2Granted

Pyrimidinyl-thiophene kinase modulators

AssigneeSGX Pharmaceuticals, Inc.

InventorsWilliam D. Arnold, Chixu Chen, Stefan N. Gradl, Stephanie A. Hopkins, Ruo W. Steensma, Masaki Tomimoto, Mark E. Wilson

Life of this patent

Estimating the term…

Abstract

The present invention provides novel pyrimidinyl-thiophene kinase modulators and methods of using the novel pyrimidinyl-thiophene kinase modulators to treat diseases mediated by kinase activity.

Claims3

Dependent claims

A compound, or salt thereof, selected from

Dependencies are inferred from the claim text.

Facts

Application: 11/556,033Filed 2 Nov 2006 · us provisional application
Priority: 3 Nov 2005
Published: US 2007/0117800 A124 May 2007
Granted: 28 Sep 2010
Term ends: Not estimatedThe source records don’t support an estimate.

Classification19 codes

C07D 409/04
Containing two hetero rings: directly linked by a ring-member-to-ring-member bond
A61P 3/00
Drugs for disorders of the metabolism
A61P 3/04
Drugs for disorders of the metabolism: anorexiants; Antiobesity agents
A61P 7/00
Drugs for disorders of the blood or the extracellular fluid

Family

Application60/733,585Us provisional application · filed 3 Nov 2005
US 2007/0117800 A1Pre-grant publication · published 24 May 2007
US 7,803,806 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…